文献速递消化道肿瘤与早癌消化内镜

锯齿状息肉病综合征患者及其亲属与散发性无蒂锯齿状病变患者的癌症风险

Cancer Risk in Patients With and Relatives of Serrated Polyposis Syndrome and Sporadic Sessile Serrated Lesions.
PubMed 文献 · Am J Gastroenterol · 2022-01-01

本研究利用犹他州人口数据库,比较锯齿状息肉病综合征(SPS)患者(n=59)、散发性无蒂锯齿状病变(SSL)患者(n=754)及性别年龄匹配的正常结肠镜对照(n=1,624)及其亲属的癌症风险。结果显示SPS患者结直肠癌风险升高10倍(P=0.04),其一级亲属升高5倍(P=0.001);SSL合并腺瘤患者的亲属结直肠癌风险增加50%。

要点

  • SPS患者结直肠癌风险较对照升高10倍(P=0.04),其一级亲属升高5倍(P=0.001)。
  • SPS患者一级亲属任何部位腺瘤/癌风险增加2.6倍。
  • SSL合并腺瘤患者的各级亲属结直肠癌风险增加50%。

核心结论

  • SPS患者及其一级亲属结直肠癌风险升高,与既往报道一致。
  • 散发性SSL患者前列腺癌风险升高。
  • 散发性SSL合并腺瘤患者的亲属结直肠癌风险可能升高,作者建议该人群加强结肠镜监测。

研究设计与样本

  • 基于犹他州人口数据库的遗传患者登记研究,纳入SPS患者59例、散发性SSL患者754例及性别年龄匹配的正常结肠镜对照1,624例。
  • 采用Cox模型校正亲属数量、亲缘等级及风险人年,评估患者及其亲属的结直肠癌、结直肠外癌及任何部位腺癌/癌风险。

主要发现

  • 与对照相比,SPS患者结直肠癌风险升高10倍(P=0.04),其一级亲属升高5倍(P=0.001)。
  • SPS患者一级亲属任何部位腺瘤/癌风险增加2.6倍。
  • SPS患者及其家庭成员未见其他常见结直肠外癌风险升高。
  • SSL合并腺瘤患者的一级、二级和三级亲属结直肠癌风险增加50%。
  • SSL患者前列腺癌风险升高。

临床怎么用

  • 作者建议对散发性SSL合并腺瘤患者的亲属加强结肠镜监测。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Patients with serrated polyposis syndrome (SPS) and their first-degree relatives (FDRs) have increased colorectal cancer (CRC) risk. Patients with sporadic sessile serrated lesion (SSL) have risk for progression to CRC. Yet familial risks of common extracolonic cancers and even CRC in these cohorts are poorly understood. Our aim was to examine cancer risk for patients with SPS and sporadic SSL and their close and more distant relatives using a large population database. METHODS: Patients with SPS (n = 59) from hereditary patient registries were eligible for study. Sporadic SSL (n = 754) and sex- and age-matched normal colonoscopy controls (n = 1,624) were selected from clinical data linked to the Utah Population Database. Cox models adjusting for the number of relatives, degree of relatedness, and person-years at risk were used to estimate CRC, extracolonic, and any-site adenocarcinoma/carcinoma cancer risk in patients and their relatives. RESULTS: Compared with controls, CRC risk was elevated 10-fold in patients with SPS (P = 0.04) and 5-fold in their FDRs (P = 0.001). Any-site adenoma/carcinoma risk was increased 2.6-fold in FDRs of patients with SPS. No elevated risks of other common extracolonic cancers were observed in SPS and family members. The FDRs, second-degree relatives, and third-degree relatives of patients with both SSL and adenomatous polyps exhibited a 50% increased CRC risk. DISCUSSION: Patients with SPS and their FDRs have an increased CRC risk, confirming other reports. Interestingly, patients with SSL were noted to have an increased risk of prostate cancer. Relatives of individuals with both sporadic SSL and adenomas, irrespective of size or dysplasia on examination, may have an elevated CRC risk, suggesting closer colonoscopy surveillance in this population.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Kanth P, Yu Z, Keener MB, et al. Cancer Risk in Patients With and Relatives of Serrated Polyposis Syndrome and Sporadic Sessile Serrated Lesions. Am J Gastroenterol. 2022. PMID: 34889311. doi:10.14309/ajg.0000000000001572

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。